Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Antibiotic Selection00:57

Antibiotic Selection

52.2K
Overview
52.2K
Cancer Vaccines01:30

Cancer Vaccines

333
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
333
Tumor Immunotherapy01:27

Tumor Immunotherapy

468
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
468
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Promoting Microbiology Literacy and Holistic Health: IMiLI and IMiLI-SAC Perspectives on Microbes, Diet, Lifestyle and Society-A 5-Year Journey.

Microbial biotechnology·2026
Same author

Development of advanced bioinformatic profiles to improve the detection and functional understanding of fungal acid phosphatases.

Applied and environmental microbiology·2026
Same author

Professional Academies: The Duty to Lead.

Microbial biotechnology·2026
Same author

MRI-based assessment and surveillance in watch-and-wait for rectal cancer: a multidisciplinary review.

European journal of radiology·2026
Same author

A Biotechnological Approach to Enzyme-Based Fertilisers: Immobilisation of Acid Phosphatases.

Microbial biotechnology·2026
Same author

Scientists' Warning to Humanity: Unnecessary Bureaucracy Is a Global Impediment to Productivity, Advancement of Human and Planetary Wellbeing, Science and Sustainability.

Microbial biotechnology·2026
Same journal

Coumarins Disrupt Cell-Cell Communication and Virulence in Priority Pathogens: Targeting the PQS Signalling System in Pseudomonas aeruginosa.

Microbial biotechnology·2026
Same journal

Engineering Pseudomonas protegens as a Targeted Antifungal-Effector Delivery Chassis via Heterologous Type III Secretion System Reconstitution.

Microbial biotechnology·2026
Same journal

Adaptive Laboratory Evolution Unlocks Membrane Permeability as a Key Limitation in Long-Chain Alcohol Metabolism by Pseudomonas putida KT2440.

Microbial biotechnology·2026
Same journal

Correction to 'Unveiling the Potential of Lentilactobacillus hilgardii in Malolactic Fermentation: Comparative Genomics and Fermentation Dynamics'.

Microbial biotechnology·2026
Same journal

NADPH Dehydrogenase Gene Regulates Energy Distribution and Fatty Acid Metabolism During Fruiting Body Formation in the Filamentous Fungus Podospora anserina.

Microbial biotechnology·2026
See all related articles

Related Experiment Video

Updated: Jun 1, 2025

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
08:11

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

12.4K

Bacteria as Precision Tools for Cancer Therapy.

Carmen Michán1, José Prados2, Juan-Luis Ramos3

  • 1Departamento de Bioquímica y Biología Molecular, Campus de Excelencia Internacional Agroalimentario CeiA3, Universidad de Córdoba, Córdoba, Spain.

Microbial Biotechnology
|January 20, 2025
PubMed
Summary
This summary is machine-generated.

Genetically engineered bacteria, like Salmonella typhimurium and Escherichia coli, show promise as cancer treatments. These microbes can target tumors, stimulate immune responses, and offer new therapeutic avenues for improved patient survival.

More Related Videos

Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

15.3K
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.5K

Related Experiment Videos

Last Updated: Jun 1, 2025

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria
08:11

Measuring Growth and Gene Expression Dynamics of Tumor-Targeted S. Typhimurium Bacteria

Published on: July 6, 2013

12.4K
Bioluminescent Bacterial Imaging In Vivo
05:06

Bioluminescent Bacterial Imaging In Vivo

Published on: November 4, 2012

15.3K
Bacterial Delivery of RNAi Effectors: Transkingdom RNAi
07:56

Bacterial Delivery of RNAi Effectors: Transkingdom RNAi

Published on: August 18, 2010

13.5K

Area of Science:

  • Microbiology
  • Oncology
  • Biotechnology

Background:

  • Discovery of cell-death-inducing genes revolutionized biocontainment of genetically modified bacteria.
  • Bacteria accumulate near tumors, presenting opportunities for novel anti-cancer strategies.
  • Understanding tumor microenvironments and immune evasion is crucial for therapeutic innovation.

Purpose of the Study:

  • To explore the potential of genetically engineered bacteria as anti-cancer agents.
  • To investigate novel therapeutic approaches utilizing bacterial vectors for cancer treatment.
  • To highlight recent advancements in bacterial-based cancer therapy.

Main Methods:

  • Engineering Salmonella typhimurium to produce in situ vaccines (flagellin-antigen complexes).
  • Utilizing gut Escherichia coli as vectors for targeted colon cancer treatment and diagnostics.
  • Assaying bacterial 'killer' genes for their efficacy against malignant cells.

Main Results:

  • Engineered S. typhimurium enhances immunogenic responses within the tumor microenvironment.
  • Engineered E. coli demonstrates potential for targeted colon cancer therapy and diagnostics.
  • Bacterial vectors show promise in overcoming tumor resistance and improving anti-cancer efficacy.

Conclusions:

  • Genetically engineered bacteria offer innovative strategies for cancer treatment.
  • Bacterial-based therapies, including in situ vaccination and targeted delivery, hold significant potential.
  • These approaches may lead to improved patient survival outcomes in cancer therapy.